DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more



Intralesional Bevacizumab Injection on Primary Pterygium

Information source: Khon Kaen University
ClinicalTrials.gov processed this data on August 20, 2015
Link to the current ClinicalTrials.gov record.

Condition(s) targeted: Pterygium; Inflammation

Intervention: Intralesional injection of bevacizumab (Drug); Topical antihistamine and vasoconstrictor (Drug)

Phase: Phase 3

Status: Recruiting

Sponsored by: Khon Kaen University

Official(s) and/or principal investigator(s):
Olan Suwan-apichon, md, Principal Investigator, Affiliation: Khon Kaen University

Overall contact:
Olan Suwan-apichon, MD, Phone: +66 43 348383, Email: osuwanapichon@hotmail.com

Summary

The purpose of this study is to evaluate that intralesional injection of bevacizumab on primary pterygium can reduce the corneal pterygium area, inflammation, redness and other symptoms.

Clinical Details

Official title: A Randomized Controlled Trial of Intralesional Bevacizumab Injection on Primary Pterygium: Preliminary Results

Study design: Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Investigator), Primary Purpose: Treatment

Primary outcome: percentage of corneal pterygium area

Detailed description: To evaluate the efficacy and safety of intralesional injection of bevacizumab on primary pterygium treatment

Eligibility

Minimum age: N/A. Maximum age: N/A. Gender(s): Both.

Criteria:

Inclusion Criteria:

- primary pterygium

Exclusion Criteria:

- previous ocular surgery

Locations and Contacts

Olan Suwan-apichon, MD, Phone: +66 43 348383, Email: osuwanapichon@hotmail.com

Srinagarind Hospital, Mueng, Khon Kaen 40000, Thailand; Recruiting
Olan Suwan-apichon, MD
Additional Information

Starting date: January 2009
Last updated: July 7, 2011

Page last updated: August 20, 2015

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017